Topics
Pharmacology
Evaluating the costs and benefits of using combination therapies
Combination therapies can help overcome treatment inertia and poor adherence in chronic disease management
Anthony Rodgers · Tracey-Lea Laba · Stephen Jan
The hidden issues of anticipatory medications in community palliative care
Keeping the doctor’s bag relevant to needs
Gerard F Gill
The benefits and harms of deprescribing
Ceasing use of medication is at least as complicated as initiating treatment in older people
Emily Reeve BPharm(Hons), PhD · Sepehr Shakib MB BS(Hons), FRACP, PhD · Ivanka Hendrix BPharm, PhD · Michael S Roberts PhD, DSc, FACP · Michael D Wiese BPharm, MClinPharm, PhD
First do no harm: a real need to deprescribe in older patients
The scale of polypharmacy-related harm is underappreciated
Ian A Scott FRACP, MHA, MEd · Kristen Anderson BPharm · Christopher R Freeman BPharm, PhD, BCACP · Danielle A Stowasser PhD, BPharm, PGDipClinHospPharm
Pharmacological management of low milk supply with domperidone: separating fact from fiction
This much maligned galactagogue may carry no direct risk to breastfeeding women
Luke E Grzeskowiak PhD, BPharm(Hons), GradCertClinEpid · Lisa H Amir MB BS, MMed, PhD
Demystifying bioequivalence
A new e-learning program provides guidance on generic medicines
Lynn M Weekes
Are high coronary risk patients missing out on lipid-lowering drugs in Australia?
Middle-aged patients with multiple risk factors appear to be well managed, but other age groups may be missing out
Leon A Simons MD, FRACP · Eric Chung BE(Comp), MBA
Role of the medical community in detecting and managing child abuse
Children in out-of-home placements have complex health needs
Klaus Martin Beckmann
The end of HIV: how do we get there?
Treatment is now the focus of prevention
Angie N Pinto FRACP, FRCPA · David Cooper AO, FAA
Antibiotic prescribing practice in residential aged care facilities - health care providers' perspectives
Health care providers identify barriers to optimal antibiotic prescribing in nursing homes
Ching Jou Lim BPharm(Hons) · Megan W-L Kwong MB BS, BMedSci · Rhonda L Stuart MB BS, FRACP, PhD · Kirsty L Buising MPH, MD, FRACP · N Deborah Friedman FRACP, MD, MPH · Noleen J Bennett PhD, MPH · Allen C Cheng FRACP, MPH, PhD · Anton Y Peleg MB BS, PhD, FRACP · Caroline Marshall FRACP, PhD, GradDipClinEpi · David C M Kong BPharm, MPharm, PhD
Black bones: minocycline-induced bone pigmentation
A known cause with no cause for alarm
Vishnusai Chauhan · Catherine McDougall
Renal replacement therapy associated with lithium nephrotoxicity in Australia
In reply -- Collaboration with nephrologists is important
Milton Roxanas · Blair S Grace · Charles R P George
Use of secondary stroke prevention medicines in Australia: national trends, 2003-2009
How does prescribing practice to prevent another stroke measure up against recommendations?
Janet K Sluggett BPharm(Hons), GDipClinEpid · Gillian E Caughey BSc(Hons), PhD · Michael B Ward BPharm(Hons), PhD · Andrew L Gilbert PhD, DipAppPsych, BPharm
Off-label prescribing
Guiding principles of the Council of Australian Therapeutic Advisory Groups should inform off-label prescribing
Madlen Gazarian · Steve Morris
Uptake of medicines and prescribing patterns in the palliative care schedule of the Pharmaceutical Benefits Scheme
The palliative care schedule is coming of age as evaluation data become available
David C Currow BMed, MPH, FRACP · Lloyd N Sansom BSc, PhD, FPS
The hidden issues of anticipatory medications in community palliative care
“Just in case” medications should be readily available in the patient’s home
Margaret O’Connor · Susan Gatens · Brian H Le
Acute allergic reaction after intravenous saline injection: an unusual presentation of chlorhexidine allergy
Serious hypersensitivity reactions can occur with very small amounts of exposure to chlorhexidine
Usman Mushtaq MB BS · Aaron Tan MB BS, FRACP · Ju Ann Tan MB BS, MRCP, FRACP · William B Smith MB BS(Hons), FRACP, PhD
A national study of the processes and outcomes of paediatric formulary applications in Australia
Paediatric hospitals are making decisions about drugs based on poor evidence and incomplete documentation
Yashwant K Sinha MB BS(Hons), FRACP, PhD · Jonathan C Craig MB ChB, FRACP, PhD · Peter G Barclay BPharm, DipHospPharm · Hugh Miller BScPharm(Hons), DipHospPharm(Admin), GradCertMan · Sean C Turner BPharm, MSc, DipClinPharm · Joseph P Whitehouse BPharm(Hons) · Jo-anne E Brien BPharm, BS(Pharm), PharmD
Prescribing statins: the real issues
Reassessing the benefits, harms and risk levels of statin therapy
Ian R Hamilton-Craig PhD, FRACP, FCSANZ
National guidelines for the management of absolute cardiovascular disease risk
Guidelines for managing cardiovascular disease risk don’t preclude combining an ACE inhibitor with an ARB
Christopher J O’Callaghan · Pei Rong · Min Y Goh
Multidrug-resistant tuberculosis in Western Australia, 1998–2012
MDR-TB remains uncommon in WA, but the challenges associated with managing it are being increasingly recognised
Joshua R Francis BAppSc(MedSc), MB BS, FRACP · Christopher C Blyth MB BS, FRACP, FRCPA · Sarah Colby MB BS · Joanna M Fagan MPH · Justin Waring MB BS, FRACP
Inadvertent dispensing of Coumadin instead of Coversyl
Two simple strategies could minimise substitution errors
Alexander M Owen · Sara L Hungerford
A functional dependence? A social history of the medical use of morphine in Australia
Morphine’s use in Australia has shaped public perception and current challenges
Matthew Grant MB BS, DipPallMed, MBioethics · Jennifer Philip PhD, FAChPM, MB BS · Anna Ugalde BA(Hons), PhD
Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget’s disease
Bisphosphonates aren’t known to cause myocardial injury, but zoledronic acid may be an exception
Monique R Watts · Andris H Ellims · David S Eccleston
Psychotropics and challenging behaviour in people with an intellectual disability
Meeting the mental health needs of people with intellectual disability is often challenging
Niki S Edwards · William Alexander · Allyson Mutch